Compare Aurora Cannabis Inc (ACB) vs iShares Semiconductor ETF (SOXX) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

SOXX, the iShares Semiconductor ETF, trades at $581.51, up 2.68% in the last 24 hours, with a neutral technical signal but bullish moving averages. The ETF has surged 93.3% year-to-date, driven by AI chip demand, yet faces recent volatility as hedge funds reduced exposure. Key support sits at $575, with resistance at $593. Financial ratios are not applicable for this ETF structure, which holds 30 U.S. semiconductor stocks.

Outlook remains cautiously optimistic given AI-driven growth, but risks include sector rotation, valuation concerns after sharp gains, and macroeconomic pressures. JPMorgan advises buying the dip, while Morgan Stanley notes potential pivot to hyperscalers. Investors should weigh strong thematic tailwinds against near-term volatility and high beta exposure.